摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-Acetamino-ethyl)-5-ethoxy-indol | 2436-11-5

中文名称
——
中文别名
——
英文名称
3-(2-Acetamino-ethyl)-5-ethoxy-indol
英文别名
N-[2-(5-ethoxy-indol-3-yl)-ethyl]-acetamide;Acetamide,n-[2-(5-ethoxy-1h-indol-3-yl)ethyl]-;N-[2-(5-ethoxy-1H-indol-3-yl)ethyl]acetamide
3-(2-Acetamino-ethyl)-5-ethoxy-indol化学式
CAS
2436-11-5
化学式
C14H18N2O2
mdl
——
分子量
246.309
InChiKey
SBWRBXMGZBMCCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    54.1
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(2-Acetamino-ethyl)-5-ethoxy-indol劳森试剂 作用下, 以 甲苯 为溶剂, 以23%的产率得到N-[2-(5-ethoxyindol-3-yl)ethyl]thioacetamide
    参考文献:
    名称:
    Binding affinity and biological activity of oxygen and sulfur isosteres at melatonin receptors as a function of their hydrogen bonding capability
    摘要:
    Analogues of melatonin (1) and of N-acetyl 5-ethoxytryptamine (3) in which the oxygen atoms are replaced by sulfur have been prepared and tested against human and amphibian melatonin receptors. All sulfur analogues show a decreased binding affinity at human NIT, and MT(2) receptors and a reduced potency as melatonin agonists on the Xenopus melanophore assay. The 5-methoxy oxygen of melatonin is significantly more important for receptor binding than the amide oxygen. N-Acetyl 5-ethoxytryptamine shows a decrease in both binding affinity and potency in comparison with melatonin. In this series, replacing either the ethoxy or amide oxygen by sulfur has a similar but smaller effect on both binding affinity and potency. Using K H values from Abraham's equations we have assessed the possibility of estimating EC(50) values for sulfur isosteres from the EC(50) values of their oxygen analogues. (C) 2003 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.bioorg.2003.09.004
点击查看最新优质反应信息

文献信息

  • NOVEL COMPOSITIONS AND METHODS FOR TREATING CANCER
    申请人:Board of Regents, The University of Texas System
    公开号:US20130129812A1
    公开(公告)日:2013-05-23
    Provided herein are methods and compositions inter alia for treating diseases, including hyperproliferative diseases, migraine headaches, and depression.
    本文提供了用于治疗疾病的方法和组合物,包括治疗增生性疾病、偏头痛和抑郁症的方法和组合物。
  • SUBSTITUTED INDOLE MCL-1 INHIBITORS
    申请人:VANDERBILT UNIVERSITY
    公开号:US20160214934A1
    公开(公告)日:2016-07-28
    The present application, among other things, provides compounds that are capable of inhibiting the activity of anti-apoptotic Bcl-2 family proteins, for example, myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides pharmaceutical compositions as well as methods for using provided compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein. In some embodiments, a provided compound has the structure of formula I. In some embodiments, a provided compound has the structure of formula II.
    本申请提供了一些化合物,其中包括能够抑制抗凋亡Bcl-2家族蛋白(例如髓系细胞白血病-1(Mcl-1)蛋白)活性的化合物。本发明还提供了制药组合物以及使用所提供化合物治疗由Mcl-1蛋白过度表达或调节失常所致的疾病和病况(例如癌症)的方法。在某些实施例中,所提供的化合物具有公式I的结构。在某些实施例中,所提供的化合物具有公式II的结构。
  • Novel Compositions and Methods for Treating Cancer
    申请人:Board of Regents, The University of Texas System
    公开号:US20150306077A1
    公开(公告)日:2015-10-29
    Provided herein are methods and compositions inter alia for treating diseases, including hyperproliferative diseases, migraine headaches, and depression.
    本文提供了治疗疾病的方法和组合物,包括治疗高增殖性疾病、偏头痛和抑郁症等疾病的方法和组合物。
  • Coated veterinary implants
    申请人:Hoechst Veterinär GmbH
    公开号:EP0246910A2
    公开(公告)日:1987-11-25
    A coated veterinary implant including (a) a veterinary implant including an effective amount of (i) an active ingredient selected from melatonin or related chemicals of the indole class, or mixtures thereof, and (ii) a veterinarily acceptable carrier or excipient, and (b) a coating for said veterinary implant (a) formed from a physiologically compatible polymeric coating composition; which implant, in use, releases the active ingredient at a rate sufficient to maintain the blood level of melatonin or related chemicals of the indole class at or above a level sufficient, and for a period sufficient, to regulate seasonal breeding activity and/or seasonal physiological responses of an animal to be treated.
    一种带涂层的兽用植入物,包括 (a) 兽用植入物,包括有效量的(i)选自褪黑素或吲哚类相关化学品或其混合物的活性成分,和(ii)兽用可接受的载体或赋形剂,和 (b) 用于所述兽用植入物 (a) 的涂层,由生理上兼容的聚合物涂层组合物形成; 该植入物在使用过程中释放活性成分的速度足以将血液中褪黑激素或吲哚类相关化学物质的水平维持在足以调节待治疗动物的季节性繁殖活动和/或季节性生理反应的水平或以上,且维持时间足以调节待治疗动物的季节性繁殖活动和/或季节性生理反应。
  • Melatonin for regulating animal reproduction
    申请人:SCHERING AGROCHEMICALS LIMITED
    公开号:EP0300630A2
    公开(公告)日:1989-01-25
    The present invention relates to a method of regulating the seasonal breeding activity and/or seasonal physiological responses of animals utilising veterinary implants. Previously described coated veterinary implants allow an active ingredient to be released at a predetermined rate to maintain a predetermined blood level of melatonin. However, the manipulation of breeding activity was limited to relative brief delays in the onset of puberty or oestrus or relatively brief advancement in the onset of puberty or oestrus. Accordingly difficulties of the prior art are substantially overcome by using the method of the invention. The method includes subjecting the animal to be treated to a first treatment with a veterinary composition including (a) an effective amount of an active ingredient selected from melatonin or related chemicals of the indole class, as hereinbefore defined, or mixtures thereof, and (b) a veterinarily acceptable carrier or excipient therefor;     at a preselected time relative to the normal breeding cycle of the animal;     and subjecting the animal to be treated to at least a second treatment with a veterinary composition as described above at a later preselected time relative to the normal breeding cycle of the animal. A composition for use in the above method is also provided.
    本发明涉及一种利用兽用植入物调节动物季节性繁殖活动和/或季节性生理反应的方法。 以前描述的带涂层的兽用植入物可按预定速率释放活性成分,以维持预定的血液褪黑激素水平。 然而,对繁殖活动的控制仅限于相对短暂地推迟青春期或发情期的到来,或相对短暂地提前青春期或发情期的到来。 因此,使用本发明的方法基本上克服了现有技术的困难。该方法包括用兽药组合物对待处理的动物进行第一次处理,兽药组合物包括 (a) 选自褪黑素或吲哚类相关化学物质(如前所述)或其混合物的有效量的活性成分,以及 (b) 兽医可接受的载体或赋形剂; 在相对于动物正常繁殖周期的预选时间; 在相对于动物正常繁殖周期的稍后预选时间,用上述兽用组合物对待处理的动物进行至少第二次处理。还提供了一种用于上述方法的组合物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物